STAT Plus: These four companies are betting big on CBD-based prescription drugs
HANS PENNINK/AP
A number of pharmaceutical companies are shepherding their CBD-based products through the lengthy and expensive FDA approval process for medicine.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario